To include your compound in the COVID-19 Resource Center, submit it here.

Addex proposes CHF40M private placement

Neurology company Addex Therapeutics Ltd. (SIX:ADXN) proposed on Feb. 15 to raise up

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE